The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
The MM&M Transforming Healthcare Conference will be held May 1 in New York City.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to:
